Halia Therapeutics works to develop medicines to treat diseases driven by chronic inflammation and neurodegeneration, according to a Jan. 19 news release from the company.
Prior to her new role, Dr. Janát-Amsbury served as an executive medical director of early oncology development and a project team lead at Amgen, a biopharmaceutical company based in Thousand Oaks, Calif.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
